UM
Managing the challenges of pharmaceutical patent expiry: a case study of Lipitor
Chao C.K.3; Hu H.3; Zhang L.2; Wu J.1
2016
Source PublicationJournal of Science and Technology Policy Management
ISSN20534639 20534620
Volume7Issue:3Pages:258-272
AbstractPurpose: The paper aims to study how global pharmaceutical companies such as Pfizer have managed the challenges of pharmaceutical patent expiry. Design/methodology/approach: A case study method was applied. The best-selling brand drug over the past 10 years – Lipitor – was chosen as the case target. Findings: For dealing with this, this paper describes all the details of the corresponding strategies of Pfizer before and after patent expiration of Lipitor. Before patent expiry, Pfizer undertook the activities of direct-to-consumer marketing, pricing strategy for competition, legal delay and me-too drug R&D. After patent expiry, Pfizer chose to carry out continuous marketing for brand, rebate strategy, authorized generics and change to over-the-counter. In addition, diversity and globalization strategy was applied before and after patent expiry. Research limitations/implications: This research provides strong implication for managing pharmaceutical products before and after patent expiry. Practical implications: It is strongly recommended for both brand and generic drug companies to design strategies to meet the challenges of pharmaceutical patent expiry. Social implications: For the global pharmaceutical market, a conclusion can be drawn that, nowadays, the “patent cliff” is the most significant factor influencing decision-makers to consider futuristic policies. Further, it is also a considerably effective solution for reducing health-care costs for policymakers. Originality/value: This paper contributes to the field of patent expiry management in high-tech industries such as pharmaceuticals.
KeywordHealth care cost Lipitor Patent expiry Pharmaceutical industry
DOI10.1108/JSTPM-12-2015-0040
URLView the original
Language英語
全文获取链接
引用统计
Document TypeJournal article
专题University of Macau
Affiliation1.University of Electronic Science and Technology of China
2.Sichuan University
3.Universidade de Macau
推荐引用方式
GB/T 7714
Chao C.K.,Hu H.,Zhang L.,et al. Managing the challenges of pharmaceutical patent expiry: a case study of Lipitor[J]. Journal of Science and Technology Policy Management,2016,7(3):258-272.
APA Chao C.K.,Hu H.,Zhang L.,&Wu J..(2016).Managing the challenges of pharmaceutical patent expiry: a case study of Lipitor.Journal of Science and Technology Policy Management,7(3),258-272.
MLA Chao C.K.,et al."Managing the challenges of pharmaceutical patent expiry: a case study of Lipitor".Journal of Science and Technology Policy Management 7.3(2016):258-272.
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
Google Scholar
中相似的文章 Google Scholar
[Chao C.K.]的文章
[Hu H.]的文章
[Zhang L.]的文章
Baidu academic
中相似的文章 Baidu academic
[Chao C.K.]的文章
[Hu H.]的文章
[Zhang L.]的文章
Bing Scholar
中相似的文章 Bing Scholar
[Chao C.K.]的文章
[Hu H.]的文章
[Zhang L.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。